Your account is not claimed yet. You can sign up with ORCID to claim your account.

Michael Grusch

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 23

Top Venues

Pharmaceutics

Cells

Cancers

Clinical cancer research : an official journal of the American Association for Cancer Research

Medical University of Vienna

University of Vienna (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical University of Vienna Jan 15o 2001

Austria

Assoc. Prof. :: Department of Medicine I; Institute of Cancer Research

Education History

University of Vienna

Austria

PHD :: Department of Pathology

Publications

Alexander Ries, Astrid Slany, Christine Pirker, Johanna C Mader, Doris Mejri, Thomas Mohr, Karin Schelch, Daniela Flehberger, Nadine Maach, Muhammad Hashim, Mir Alireza Hoda, Balázs Dome, Georg Krupitza, Walter Berger, Christopher Gerner, Klaus Holzmann, Michael Grusch
Primary and hTERT-Transduced Mesothelioma-Associated Fibroblasts but Not Primary or hTERT-Transduced Mesothelial Cells Stimulate Growth of Human Mesothelioma Cells. Cells 12 (15) (2023)
Berta Mosleh, Karin Schelch, Thomas Mohr, Thomas Klikovits, Christina Wagner, Lukas Ratzinger, Yawen Dong, Katharina Sinn, Alexander Ries, Walter Berger, Bettina Grasl-Kraupp, Konrad Hoetzenecker, Viktoria Laszlo, Balázs Dome, Balazs Hegedüs, Marko Jakopovic, Mir Alireza Hoda, Michael Grusch
Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis. Thoracic cancer (2023)
Theresa Mendrina, Isabella Poetsch, Hemma Schueffl, Dina Baier, Christine Pirker, Alexander Ries, Bernhard K Keppler, Christian R Kowol, Dan Gibson, Michael Grusch, Walter Berger, Petra Heffeter
Influence of the Fatty Acid Metabolism on the Mode of Action of a Cisplatin(IV) Complex with Phenylbutyrate as Axial Ligands. Pharmaceutics 15 (2) (2023)
Miroslav Mišík, Michael Kundi, Nadine Worel, Franziska Ferk, Hans-Peter Hutter, Michael Grusch, Armen Nersesyan, Denise Herrera Morales, Siegfried Knasmueller
Impact of Mobile Phone Specific Electromagnetic Fields on DNA Damage Caused by Occupationally Relevant Exposures: Results of ex vivo Experiments with Peripheral Blood Mononuclear Cells from Different Demographic Groups. Mutagenesis (2023)
Theresa Mendrina, Isabella Poetsch, Hemma Schueffl, Dina Baier, Christine Pirker, Alexander Ries, Bernhard K Keppler, Christian R Kowol, Dan Gibson, Michael Grusch, Walter Berger, Petra Heffeter
Influence of the Fatty Acid Metabolism on the Mode of Action of a Cisplatin(IV) Complex with Phenylbutyrate as Axial Ligands. Pharmaceutics 15 (2) (2023)
Zsuzsanna Valko, Zsolt Megyesfalvi, Anna Schwendenwein, Christian Lang, Sandor Paku, Nandor Barany, Bence Ferencz, Anita Horvath-Rozsas, Ildiko Kovacs, Erzsebet Schlegl, Veronika Pozonec, Kristiina Boettiger, Melinda Rezeli, Gyorgy Marko-Varga, Ferenc Renyi-Vamos, Mir Alireza Hoda, Thomas Klikovits, Konrad Hoetzenecker, Michael Grusch, Viktoria Laszlo, Balázs Dome, Karin Schelch
Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer. British journal of cancer (2023)
Theresa Mendrina, Isabella Poetsch, Hemma Schueffl, Dina Baier, Christine Pirker, Alexander Ries, Bernhard K Keppler, Christian R Kowol, Dan Gibson, Michael Grusch, Walter Berger, Petra Heffeter
Influence of the Fatty Acid Metabolism on the Mode of Action of a Cisplatin(IV) Complex with Phenylbutyrate as Axial Ligands. Pharmaceutics 15 (2) (2023)
Theresa Mendrina, Isabella Poetsch, Hemma Schueffl, Dina Baier, Christine Pirker, Alexander Ries, Bernhard K Keppler, Christian R Kowol, Dan Gibson, Michael Grusch, Walter Berger, Petra Heffeter
Influence of the Fatty Acid Metabolism on the Mode of Action of a Cisplatin(IV) Complex with Phenylbutyrate as Axial Ligands. Pharmaceutics 15 (2) (2023)
Anna Solta, Kristiina Boettiger, Ildikó Kovács, Christian Lang, Zsolt Megyesfalvi, Franziska Ferk, Miroslav Mišík, Konrad Hötzenecker, Clemens Aigner, Christian R Kowol, Siegfried Knasmueller, Michael Grusch, Beáta Szeitz, Melinda Rezeli, Balázs Dome, Karin Schelch
Entinostat enhances the efficacy of chemotherapy in small cell lung cancer through S-phase arrest and decreased base excision repair. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Karin Schelch, Sebastian Eder, Benjamin Zitta, Monica Phimmachanh, Thomas G Johnson, Dominik Emminger, Andrea Wenninger-Weinzierl, Caterina Sturtzel, Hugo Poplimont, Alexander Ries, Konrad Hoetzenecker, Mir A Hoda, Walter Berger, Martin Distel, Balazs Dome, Glen Reid, Michael Grusch
YB-1 regulates mesothelioma cell migration via Snail but not EGFR, MMP1, EPHA5 or PARK2. Molecular oncology (2022)
Karin Schelch, Sebastian Eder, Benjamin Zitta, Monica Phimmachanh, Thomas G Johnson, Dominik Emminger, Andrea Wenninger-Weinzierl, Caterina Sturtzel, Hugo Poplimont, Alexander Ries, Konrad Hoetzenecker, Mir A Hoda, Walter Berger, Martin Distel, Balazs Dome, Glen Reid, Michael Grusch
YB-1 regulates mesothelioma cell migration via snail but not EGFR, MMP1, EPHA5 or PARK2. Molecular oncology (2022)
Randa Naffa, Lisa Vogel, Luca Hegedűs, Katalin Pászty, Sarolta Tóth, Kornélia Kelemen, Neha Singh, Attila Reményi, Enikő Kállay, Mihály Cserepes, József Tóvári, Michael Grusch, Ágnes Enyedi
P38 MAPK Promotes Migration and Metastatic Activity of BRAF Mutant Melanoma Cells by Inducing Degradation of PMCA4b. Cells 9 (5) (2020)
Christine Pirker, Agnes Bilecz, Michael Grusch, Thomas Mohr, Barbara Heidenreich, Viktoria Laszlo, Paul Stockhammer, Daniela Lötsch-Gojo, Johannes Gojo, Lisa Gabler, Sabine Spiegl-Kreinecker, Balazs Dome, Ariane Steindl, Thomas Klikovits, Mir Alireza Hoda, Marko Jakopovic, Miroslav Samarzija, Katja Mohorcic, Izidor Kern, Barbara Kiesel, Luka Brcic, Felicitas Oberndorfer, Leonhard Müllauer, Walter Klepetko, Wolfgang M Schmidt, Rajiv Kumar, Balazs Hegedüs, Walter Berger
Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (14) (2020)
Jakob Paur, Maximilian Valler, Rebecca Sienel, Karin Taxauer, Klaus Holzmann, Brigitte Marian, Andreas Unterberger, Thomas Mohr, Walter Berger, Andja Gvozdenovich, Johannes Schimming, Michael Grusch, Bettina Grasl-Kraupp
Interaction of FGF9 with FGFR3-IIIb/IIIc, a putative driver of growth and aggressive behaviour of hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 40 (9) (2020)
Slavisa Tubin, Seema Gupta, Michael Grusch, Helmuth H Popper, Luka Brcic, Martin L Ashdown, Samir N Khleif, Barbara Peter-Vörösmarty, Martin Hyden, Simone Negrini, Piero Fossati, Eugen Hug
Shifting the Immune-Suppressive to Predominant Immune-Stimulatory Radiation Effects by SBRT-PArtial Tumor Irradiation Targeting HYpoxic Segment (SBRT-PATHY). Cancers 13 (1) (2020)
Alexander Ries, Karin Schelch, David Falch, Laura Pany, Mir Alireza Hoda, Michael Grusch
Activin A: an emerging target for improving cancer treatment? Expert opinion on therapeutic targets 24 (10) (2020)
Thomas G Johnson, Karin Schelch, Kaitao Lai, Kamila A Marzec, Marina Kennerson, Michael Grusch, Glen Reid, Andrew Burgess
YB-1 Knockdown Inhibits the Proliferation of Mesothelioma Cells through Multiple Mechanisms. Cancers 12 (8) (2020)
Eszter Molnár, Tamás Garay, Marco Donia, Marcell Baranyi, Dominika Rittler, Walter Berger, József Tímár, Michael Grusch, Balazs Hegedüs
Long-Term Vemurafenib Exposure Induced Alterations of Cell Phenotypes in Melanoma: Increased Cell Migration and Its Association with EGFR Expression. International journal of molecular sciences 20 (18) (2019)
Gregor Vlacic, Mir A Hoda, Thomas Klikovits, Katharina Sinn, Elisabeth Gschwandtner, Katja Mohorcic, Karin Schelch, Christine Pirker, Barbara Peter-Vörösmarty, Jelena Brankovic, Balazs Dome, Viktoria Laszlo, Tanja Cufer, Ales Rozman, Walter Klepetko, Bettina Grasl-Kraupp, Balazs Hegedüs, Walter Berger, Izidor Kern, Michael Grusch
Expression of FGFR1-4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity. Cells 8 (9) (2019)
Mohammad Hasan Soheilifar, Michael Grusch, Hoda Keshmiri Neghab, Razieh Amini, Hamid Maadi, Massoud Saidijam, Zhixiang Wang
Angioregulatory microRNAs in Colorectal Cancer. Cancers 12 (1) (2019)
Bernhard Englinger, Sebastian Kallus, Julia Senkiv, Anna Laemmerer, Patrick Moser, Lisa Gabler, Diana Groza, Christian R Kowol, Petra Heffeter, Michael Grusch, Walter Berger
Lysosomal Sequestration Impairs the Activity of the Preclinical FGFR Inhibitor PD173074. Cells 7 (12) (2018)
Sonja Hager, Katharina Korbula, Björn Bielec, Michael Grusch, Christine Pirker, Markus Schosserer, Lisa Liendl, Magdalena Lang, Johannes Grillari, Karin Nowikovsky, Veronika F S Pape, Thomas Mohr, Gergely Szakács, Bernhard K Keppler, Walter Berger, Christian R Kowol, Petra Heffeter
The thiosemicarbazone Me2NNMe2 induces paraptosis by disrupting the ER thiol redox homeostasis based on protein disulfide isomerase inhibition. Cell death & disease 9 (11) (2018)
Thomas Klikovits, Paul Stockhammer, Viktoria Laszlo, Yawen Dong, Mir Alireza Hoda, Bahil Ghanim, Isabelle Opitz, Thomas Frauenfelder, Thi Dan Linh Nguyen-Kim, Walter Weder, Walter Berger, Michael Grusch, Clemens Aigner, Walter Klepetko, Balazs Dome, Ferenc Renyi-Vamos, Rudolf Oehler, Balazs Hegedüs
Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma. Scientific reports 7 (1) (2017)

Michael Grusch.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Michael Grusch